The Sapphire investigation reported that elevated plasma TIMP-2 and IGFBP7 identified patients with moderate-severe AKI facing the highest mortality risk with an AUC of 0.79–0.82 [89]. This evidence concerns the gene TIMP2 and acute kidney injury.